MRD-guided Treatment in NPM1mut AML Patients
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE3
Pevonedistat With Azacitidine Versus Azacitidine Alone in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
- Status
- RECRUITING
- Phase
- PHASE2
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486
- Status
- COMPLETED
- Phase
- PHASE2